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Oxygen Mapping of Melanoma 
Spheroids using Small 
Molecule Platinum Probe and 
Phosphorescence Lifetime Imaging 
Microscopy
Ahtasham Raza1, Helen E. Colley2, Elizabeth Baggaley3, Igor V. Sazanovich4, Nicola H. Green  1, 
Julia A. Weinstein3, Stanley W. Botchway4, Sheila MacNeil1 & John W. Haycock  1
Solid tumours display varied oxygen levels and this characteristic can be exploited to develop new 
diagnostic tools to determine and exploit these variations. Oxygen is an efficient quencher of emission 
of many phosphorescent compounds, thus oxygen concentration could in many cases be derived 
directly from relative emission intensity and lifetime. In this study, we extend our previous work on 
phosphorescent, low molecular weight platinum(II) complex as an oxygen sensing probe to study the 
variation in oxygen concentration in a viable multicellular 3D human tumour model. The data shows one 
of the first examples of non-invasive, real-time oxygen mapping across a melanoma tumour spheroid 
using one-photon phosphorescence lifetime imaging microscopy (PLIM) and a small molecule oxygen 
sensitive probe. These measurements were quantitative and enabled real time oxygen mapping with 
high spatial resolution. This combination presents as a valuable tool for optical detection of both 
physiological and pathological oxygen levels in a live tissue mass and we suggest has the potential for 
broader clinical application.
The use of metal complexes as dyes and probes for emission-based cellular imaging has developed into a vibrant 
area of research over the past decade1–3. This emerging class of probes offers photo-physical properties that differ 
to a range of commercially available organic probes, and is enabling a new range of technologies to be explored. 
Notably, recent advances in optics and electronics, combined with the long emission lifetimes typical for transi-
tion metal complexes (from hundreds of nanoseconds to microseconds), has resulted in the emergence of mul-
tiphoton microsecond lifetime mapping techniques, such as Phosphorescence Lifetime Imaging Microscopy 
(PLIM)4, 5 and Time-Resolved Emission Imaging Microscopy (TREM)4.
Luminescent transition metal complexes typically emit from a triplet excited state. Although transitions 
between states of a different spin are formally forbidden, intersystem crossing to the triplet state and subsequent 
relaxation to the ground state via phosphorescence are facilitated in transition metal complexes by the high spin 
orbit coupling constant associated with the heavy metal atom. The forbidden nature of the phosphorescence 
transition, results in a slow rate of emission; hence phosphorescence lifetimes are typically the order of hundreds 
of nanoseconds to microseconds. It is well documented that molecular oxygen quenches such triplet emitters and 
that the rate of quenching is dependent on oxygen concentration5–10. One application of phosphorescent emitters 
in biological imaging is in oxygen detection, where more sensitive, non-invasive methods are in demand. The 
combination of phosphorescence quenching and high-resolution lifetime imaging is a powerful approach for 
non-invasive, real-time hypoxia detection and oxygen quantification.
Oxygen quantification in biological systems is primarily focused on the use of large platinum and palladium 
porphyrins. These compounds display long emission lifetimes (typically 40–60 µs), which typically decreases 
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upon exposure to oxygen. They have been successfully used for measuring bulk intracellular oxygen concentra-
tions in a range of models. Thus they have been used in an intensity-based, high-throughput method utilizing a 
time-resolved fluorescence plate reader5–7; in determining oxygen gradients across 2D monolayers, 3D neuros-
pheres and spheroids using a combination of single photon time correlated single photon counting (TCSPC) and 
PLIM; in measuring in-vivo oxygen concentration changes in the blood stream of live animals, using bespoke 
multi-photon microscope10–13.
Efficient cellular uptake can be problematic with porphyrins, due to their large size. For some applications, 
such as intra-cellular and blood oxygen concentrations, this is a positive attribute as it prevents the porphyrin 
from sequestering into the surrounding cells or tissue. For intercellular oxygen determination and penetration 
into larger or deeper samples, it is a major drawback. This problem has been overcome in some cases by the addi-
tion of cell-penetrating moieties, specific cell markers or encapsulation in nanoparticles, however, these systems 
are complex and require long multi-step syntheses.
Phosphorescence quenching offers a direct, real-time and quantitative method for oxygen determination14–16. 
To obtain a detailed relationship between cellular location of the probe and its emission lifetime (and therefore 
oxygen concentration) excellent spatial and temporal resolution is required. Intensity based imaging using wide 
field illumination will only give a general picture of the oxygen concentration as the intensity information will 
be averaged in the ‘z’ direction. Furthermore, intensity based images can be affected by background emission, 
probe concentration, imaging parameters and photobleaching. Lifetime mapping using a point-by-point scan-
ning method, such as that used in confocal imaging, with time correlated single photon counting, offers a more 
accurate method that circumvents many of the drawbacks associated with intensity imaging. Yet there is a hurdle: 
the longer the lifetime of the O2 probe, the longer the image acquisition time. To establish a lifetime decay at 
each pixel (in a typical 256 × 256 array), with a good signal-to-noise, the microscope scan head must remain at 
each pixel for a period of time that is 5 to 6 times longer than the emission lifetime of the probe, and over tens or 
hundreds of frame scans. Therefore, porphyrins with very long emission lifetimes require very long acquisition 
times, over which sample drifting can be a problem. One solution is to sacrifice spatial resolution by using a 
smaller number of larger pixels. Alternatively, using an oxygen responsive probe with a shorter emission lifetime 
can reduce sampling time.
Small molecule transition metal complexes with emission lifetimes on the order of hundreds of nanoseconds 
to microseconds provide an alternative that requires less of a trade-off between resolution and speed, with simpler 
synthetic procedures. Some transition metal complexes can penetrate living cells without the need for elaborate 
synthetic modification and in some cases demonstrate specificity to particular organelles, which can be desirable 
when investigating oxygen changes as a response to external stimuli.
We have previously reported on the application of a series of small luminescent platinum (II) complexes 
PtLnCl for in vitro live cell imaging and two-photon lifetime mapping using TCSPC17, 18. This family of complexes 
(where L is a cyclometalating 3-di(2-pyridyl)benzene) based ligand) (Fig. 1) exhibit microsecond emission life-
times (τ0 = 7 µs in CH2Cl2), high emission quantum yields (c.a. 70%)19, excellent photostability and low cytotox-
icity. Previous studies have investigated the mechanism of entry across human fibroblast and melanoma cells in 
vitro, and report on properties that enable passage across intact cell membranes via diffusion after incubation 
with PtLnCl for 5 minutes, permitting imaging thereafter17. Moreover, these PtLnCl complexes have a relatively 
short synthetic pathway, which can be accelerated by microwave-assisted methods20. We have already demon-
strated that the emission lifetime of complexes of this type varies with exposure to oxygen inside living cells 
(CHO cell cytoplasm from 95% N2/5% Co2 from 1.49 µs to 6 µs4, 18). Cytosol staining appears uniform under 
two-photon excitation and exhibits the lowest level of protection from collisional quenching, making these com-
plexes an excellent choice for oxygen detection via phosphorescence quenching. Another key advantage of such 
small Pt(II) molecules is their diffusion controlled intracellular accumulation without an active intake pathway, 
which makes them ideal as probes for experimental systems such as 3D tumour spheroid models.
Figure 1. Structure of PtLsCl.
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Multicellular tumour spheroids (MCTS) involve culturing cancer cells in a non-adherent environment, which 
consequently stimulates them to adhere with one another21, 22. These solid aggregates resemble an avascular 
tumour23. The model provides an assay to study the tumour microenvironment where the outermost layers of 
cells receive nutrients by diffusion and discard waste products into culture medium. However, the innermost cells 
outgrow the natural diffusion range of nutrients, oxygen and waste products, leading to formation of hypoxia and 
necrosis within the inner ‘core’ areas. The extent of these features can be controlled experimentally as they are 
determined by the type of cells in culture, the size of the MCTS, time in culture, together with the proliferation 
rate of the cancer cells in question.
It has been established that not all cell types have the ability to form spheroids, and some cell types form irreg-
ular shaped aggregates rather than spheroids. The heterogeneity of cells and the metabolic gradients (including 
oxygen, glucose, ATP) become apparent in spheroids only when they are larger than 150 µm. The appearance of a 
necrotic and hypoxic central region becomes apparent only after a diameter of ~500 µm23–25. Therefore, 3D MCTS 
models can be exploited as a structural model with a necrotic central core due to: (i) deficiency of nutrients and 
metabolites; (ii) variation in oxygen concentration; (iii) accumulation of waste products and (iv) low pH. These 
are some characteristics related to the phenomena seen in vivo of a solid tumour over a distance >100 µm from 
a blood supply26, 27.
Extending upon previous studies using small molecule Pt dyes4, 17, 18, herein we use a human melanoma 
multi-cellular tumor spheroid model in a longitudinal study and investigate the small molecule Pt dye for vari-
ations in oxygen tension. This progresses previous single melanoma cell reports to an organoid study of physio-
logical context. We demonstrate the first example of a small-molecule platinum (II) complex for oxygen mapping 
using one-photon phosphorescence lifetime imaging microscopy, which provides a non-invasive imaging modal-
ity for oxygen distribution across live human melanoma tumour spheroids at various stages of development.
Results
To mimic solid tumour conditions, we used a melanoma multi-cellular tumour spheroid model (MCTS). MCTS 
models exhibit characteristics of an in vivo solid tumour, such as, heterogeneous proliferative and necrotic cells 
and varied metabolic gradients of oxygen, nutrients and waste product23, 28. These tumour microenvironments 
exhibit three distinct regions of oxygenation28–30, simulating the oxygen gradient found across a solid tumour; 
where the majority of tumour cells located close to a blood vessel are proliferative while the inner area (far from 
the blood vessel) is made up of hypoxic and anoxia cells29. Using an in vitro melanoma C8161 tumour spheroid 
model (between 100 µm and 1000 µm in diameter) we successfully characterized these three physically distinct 
regions: (a) a proliferative viable region of human melanoma cells, (b) an inner hypoxic region and (c) a central 
necrotic core, using complementary methods of light microscopy, histology, immunohistochemistry and phos-
phorescence lifetime mapping.
MCTS growth. Three different human melanoma cell lines (A375-SM, HBL and C8161) were initially inves-
tigated for their ability to form multi-cellular tumour spheroids (MCTS) in vitro, using an established liquid over-
lay technique21. C8161 melanoma cells were the most successful, forming compact MCTS within first 1–2 days of 
culture with a very high yield of 90 to 100%. A seeding density of 12,000 cells was selected as the optimal starting 
point for the C8161 MCTS model (from a range tested across 750–24,000 (Figure SI1). The size (diameter) of mel-
anoma MCTS determined over a 10-day growth period by phase contrast microscopy (Figure SI1) showed initial 
exponential growth, from 553 µm ± 25.5 (n = 66) at day 4 to 952 µm ± 48.5 (n = 66) at day 10, with a volume dou-
bling time of 8 days. No stationary phase was observed under these conditions. An outer region clearly comprised 
of a cellular mass and a central region devoid of cells was evident after 4 days in culture, by light microscopy 
(Figure SI1). This was not the case seen with a lower seeding densities (7,500 and 1,500), where an exponential 
growth in early spheroid development was observed followed by a later stationary phase at 8 to 10 days. MCTS 
cultured for 5 different time periods (2, 4, 8 and 10 days) were fixed and processed for histology. Haemotoxylin & 
eosin staining (Fig. 2A,B) revealed a uniformly stained cell mass at 2 days, and a central area visible after 4 days, 
which did not take up H&E stain and which increased in size over time. This lack of staining was attributed to a 
reduction in cellular mass in the central core of the spheroid, and arises from the formation of debris following 
cell death. It was therefore referred to as a necrotic area. This observation was consistent with Ki-67 staining 
(Fig. 2E), which identified proliferating cells (in brown) across the entire spheroid at day 2, but was restricted to 
the edges of spheroids by day 8. Spheroid formation at day 2 was therefore predominantly via cell division due to 
the extent of Ki67 uniformity, but may include a degree of aggregation or coalescence at this early stage.
The radius of the unstained necrotic region increased in size from 65.6 µm (±22.5) on day 4 to 338.2 µm 
(±11.8 µm) (n = 10) on day 10, whereas the proliferative area reduced in size from 186.4 µm (±31.3) to 109.7 µm 
(±5.7) µm (Fig. 2B). After 8 to 10 days in culture, the cellular mass was not homogenous across the spheroids. 
Cells near to the periphery were loosely attached and had a large extracellular space compared with medially 
located cells, which were very tightly packed. The core was observed to contain a very small number of cells with 
mostly cell debris. The results clearly showed that formation of an un-stained central core was dependent on the 
size of the spheroid and the time in culture.
Oxygen profiling. End-point detection. Hypoxic regions within MCTS across different growth stages were 
detected using pimonidazole hydrochloride with immuno-labelling of protein adducts of reductively activated 
pimonidazole as evidence of hypoxia. A commercially available kit (Hypoxyprobe™) was employed using the 
pimonadizole as an oxygen marker that binds only to cells with an oxygen saturation less than pO2 of 10mm Hg 
at 37 °C31. In MCTS at day 4 a central hypoxic area was observed (red, Fig. 2B, radius = 87 ± 18 µm), which devel-
oped in to a ring-like structure, surrounding the central un-stained core after 8 and 10 days (radius = 159 ± 36 µm 
(8 days) and 109 ± 6 µm (10 days), respectively). Evaluation of MCTS using Hypoxyprobe™, Ki-67 and 
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haemotoxylin & eosin staining all revealed the presence of a central core (by day 8) that exhibited negative stain-
ing in this region. This was attributed to the presence of necrosis, consisting mostly of cellular debris as a result of 
deprivation of inwardly diffusing and transported nutrients. Cumulatively, the data showed that C8161 melanoma 
MCTS grown between 4 and 8 days and greater than 500 µm in size exhibit three distinct regions: an inner central 
necrotic region, an intermediate hypoxic region and an outer proliferative region. Hypoxyprobe™ was not much 
expressed in the necrotic area of the spheroid merely due to presence of less or no cells in necrotic area, which was 
consistent with previous data reported for cervix carcinoma31, 32. It is believed that the Hypoxyprobe™ positive 
regions are localized to a viable tumour, conversely necrotic cells are unable to metabolize the marker and were 
Figure 2. Morphology of C8161 MCTS. (A) H&E of human melanoma C8161 MCTS after 2, 4, 8 and 10 
days in culture (Magnification 10X, scale bar = 100 μm). (B) Measurement of outer and inner necrotic area 
of MCTS (n = 10, mean ± S.E). (C) Immuno-labelling of melanoma C8161 MCTS by Hypoxyprobe™ (red), 
counterstained with DAPI (blue) (Magnification 20X, scale bar = 100 μm). (D) Measurement of outer area, 
hypoxic area and central necrotic area of MCTS with respect to time in culture (n = 10, mean ± S.E).  
(E) C8161 MCTS stained with anti-Ki67 to show proliferating cells (brown) counterstained with haematoxylin 
(Magnification 10X, scale bar = 200 µm).
www.nature.com/scientificreports/
5SCientifiC REPORtS | 7: 10743  | DOI:10.1038/s41598-017-11153-9
therefore do not express immunoreactive sites. However, the Hypoxyprobe™ method, while validated in a num-
ber of clinical and experimental studies31, is only able to detect areas of hypoxia within a spheroid as an indirect 
endpoint method, and lacks quantitative analysis. To obtain non-invasive, real-time O2 quantification within a 
spheroid model, we therefore correlated the data obtained above, by histology and hypoxia, with phosphores-
cence lifetime mapping using a small platinum (II) molecule O2 sensor and PLIM11, 12, 33, 34.
Real-time mapping of tumour growth using Pt-label and PLIM. To map the oxygen concentration across the 
width and depth of the C8161 human melanoma MCTS using PtLsCl and lifetime mapping, we first assessed 
the penetrative ability of the PtLsCl in to the spheroids by steady-state microscopy under two-photon excitation 
(λex = 800 nm and λem = 500–550). Previous studies (and this work, see SI) on 2D cell monolayers demonstrated 
that PtLsCl is rapidly taken up by living cells after just 5 minutes incubation at 100 µM. In contrast, at the same 
concentration, we found that PtLsCl required 12 hours at 37 °C to completely penetrate though a C8161 mel-
anoma spheroid of <500 µm in diameter. (Higher concentrations of label (up to 1000 μM) for 5 minutes incu-
bation did not penetrate significantly beyond the outer cell layer, and was similar to the depth observed using 
100 μM). PtLsCl uptake and distribution was uniform across spheroids of different sizes at different growth stages 
(Figure SI2A–D). Penetration though a typical spheroid was confirmed via emission spectra and steady-state 
two-photon imaging (Figure S2E) at a range of depths.
The emission lifetime of PtLsCl in solution is significantly reduced in the presence of oxygen (from τ = 5.4 
µs without oxygen, to τ0 = 0.17 µs in aerated DMF [4]). Previous studies (and this work, see SI) also show that 
the probe remains sensitive to oxygen when inside a living cell; exemplified by the variation in emission lifetime 
across a single cell where τnucleoli ~ 7 µs > τnucleus ~ 5.6 µs > τcytosol ~ 4.0 µs (Figure SI3) as a result of different bind-
ing environments offering different levels of protection from collisional quenching with dissolved oxygen. Using 
these data, we investigated the emission lifetime of PtLsCl under PLIM in the melanoma MCTS model.
A Becker & Hickl (GmbH) time correlated single photon counting (TCSPC) module, coupled to a confocal 
microscope and a photomultiplier, was used for photon detection. In a one-photon set-up the pixel clock, which 
controls the scan head of the microscope, acts as the trigger for the TCSPC module enabling the emission decay of 
each pixel in the 256 × 256 array to be analysed independently of one another. To construct lifetime maps, decay 
traces for all pixels across the 256 × 256 array (or those selected as a region of interest) were fitted to a double 
exponential model, with a bin (averaging parameter) of 2, and τi was plotted as a rainbow chart (and as discrete 
colours) to show the lifetime variation (and distinct regions) across the melanoma spheroids. The decay kinetics 
of PtLsCl emission can be readily quantified in different cells and in different regions of a cell and tissue (Figs 3 
and 4 and SI 3). A bi-exponential fit was reported previously both in cells and tissue4, 17. Hereby, it was observed 
that the temporal decay in melanoma spheroid fits well to a bi-exponential function. This bi-exponential decay 
kinetics is probably a simplest reflection of the complex distribution of tissue microenvironment and binding 
modes anticipated for the PtLsCl with the tissue.
PLIM revealed that the emission lifetime of PtLsCl in MCTS could be classified in to three distinct ranges; 
the shortest lifetime (ca. 0–4 µs, red, discrete scale) were observed at the outer edges of the MCTS, which 
increased to c.a 4–6.5 µs (green) then ca. 6.5–12 µs (blue) with increased proximity to the centre of the spheroid 
(decay best fit to a double exponential in all cases) (Figs 3 and 4). These distinct regions correlate clearly with 
Hypoxyprobe™ and Ki-67 staining, revealing the presence of an outer proliferative rim (τ = 2.14 ± 0.2 µs), an 
inner (or intermediate) hypoxic region (τ = 6.7 ± 0.5 µs) and a central necrotic core (τ = 9.6 ± 0.4 µs) at a depth 
of 80 µm. Furthermore, emission lifetime observed at the proliferative rim where cells have a good exchange of 
nutrients and waste products, match those observed in the cytosol of single cell monolayers (see SI, Figure S3). 
This distribution in emission lifetime and therefore oxygen concentration across the 3D spheroid is indicative of 
a solid microenvironment where physical structures for diffusion-limited conditions exist. Distribution of PtLsCl 
lifetimes in monolayers of human HBL melanoma and HaCat keratinocyte cells also followed the previously 
observed trend of emission lifetime in the nucleoli > nucleus > cytoplasm, (see SI, Table 1).
PLIM lifetime maps. This is the first example of real-time oxygen mapping across a 3D human spheroid model 
using one-photon PLIM imaging, at high resolution. The data has provided a spatial-lifetime across the section 
of the spheroid, with enhanced resolution in the x, y plane revealing a clear cellular structure at the edges of the 
spheroid where the cells are intact and proliferating normally, and a lack of structure at the centre of the spheroid 
where there is mostly cell debris. Z-stacking data obtained by PLIM (Fig. 4) did reveal an increase in emission 
lifetime with increasing depth at the centre of the spheroid, indicative of an oxygen deficient core. However, 
this was limited to 100 µm due to relative penetration and high light scattering thereafter where no clear cellular 
structure could be observed.
Discussion
Intracellular oxygen concentrations play a critical role in many physiological and pathological pro-
cesses35, 36. The measurement of oxygen is important for assessing cellular activity and in clinical diagnosis, 
tumour chemo-sensitivity, in pharmacological drug screening and for environmental toxicant screening. 
Furthermore, changes in oxygen levels during tumour development can form the basis for the identification of 
neoplastically-transformed cells as micro-tumours26, 27.
PtLsCl lifetime mapping using PLIM on MCTS of different sizes and growth stages cumulatively showed 
large spheroids having a significant lifetime-oxygen gradient, while smaller and earlier growth stage spheroids 
showed no such gradient. This heterogeneity in lifetime was dependent on spheroid culture conditions. Finally, 
pixel-by-pixel measurements of lifetime in these three distinct areas allowed demographic quantification of aver-
age lifetimes values in spheroids across the z-axis, illustrating a sensitive, real-time, quantification technique.
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Moreover, we observed a diffusion limited cell permeability property of the small molecule PtLsCl type, and 
diffusion-limited properties through a multi-layered tumour spheroid, where a longer incubation time using the 
same concentration as for single cell imaging was required. This property, in combination with a high emission 
quantum yield and moderately long emission lifetime, which is strongly oxygen sensitive, offers a simple imaging 
procedure. This has potential in terms of PLIM acquisition times where subsequent excitation pluses must be 
separated by at least 4 to 5 times the length of the emission lifetime of the phosphorescent probe. Following on 
from this study we aim to investigate the full optical slicing ability of two-photon PLIM with PtLsCl, to assess 
applicability (via topical application) in keratinized cancer skin models for broader clinical applications of mel-
anoma diagnosis.
The present study demonstrates a novel approach for the detection of relative oxygen levels in a melanoma 
tumour tissue mass, based on the ability to combine PLIM and single-photon excitation in combination with an 
oxygen sensitive platinum label. Given that solid tumours display varied oxygen levels, this characteristic can 
be exploited to develop new diagnostic tools to determine and exploit these variations and we therefore present 
this as a novel optical method. The data shows one of the first examples of non-invasive oxygen mapping across a 
melanoma tumour spheroid using one-photon PLIM, revealing a variation in lifetime that correlated with oxygen 
concentration. These measurements were quantitative and enabled real time oxygen mapping with enhanced 
spatial resolution.
There is experimental data that suggests that hypoxic cells within tumour microenvironments are less sensi-
tive to chemotherapy and radiotherapy. In addition, it has been suggested that tumour hypoxia may also relate to 
malignant progression37, 38. Our PtLsCl probe along with confocal PLIM provides information that may be useful 
in selecting patients who would benefit from new hypoxic- targeted therapy39. We suggest that the development 
of a non-invasive 3D mapping of the tumour microenvironment with high resolution will open up new avenues 
for therapeutic interventions. For example, investigating the hypoxic environment of a tumour in vivo would be 
Figure 3. Lifetime distribution of PtLsCl (100 µM, 12 hours) in melanoma MCTS using one-photon PLIM. 
PtLsCl lifetime distribution across spheroid represented as: (A) Continuous rainbow scale, range: 0–11.5 µs. 
(B) Discrete colours, reveals three distinct spheroid regions: an outer proliferative rim (red, 0–3.0 µs), an 
intermediate necrotic region (green, 3.0–7.5 µs) and an inner necrotic core (blue, 7.5–12.0 µs). (Magnification 
40x scale bar = 100 µm). (C) Emission decay observed in inner (a), middle (b) and outer (a) area of spheroid 
showed short-lived emission in outer area and a longer emission in inner area.
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of value in the surgical management of melanoma or in the use of high precision irradiance modulation to achieve 
selective dose escalation in chemo/radio resistant hypoxic cells within the tumour microenvironment. The study 
of this family of probes benefits from access to multiphoton microscopy.
Parallel developments in dyes and imaging technology are also being studied40. The direction of research is 
that it should prove possible to use fibre optic probes for use in the clinic, which would allow the interrogation of 
tumours within the skin up to a depth of 0.5 mm, sufficient to detect surface, deep and metastasising melanoma 
leaving the primary tumour. Thus, one can excite the compound with 400 nm light, and emission is such that fibre 
optic excitation with long or short wave light will still lead to a desired measurement. We therefore suggest PLIM 
incorporated with PtLsCl probes may be developed as a technology and optical tool for the detection of both 
physiological and pathological oxygen levels in live tumour tissue mass, with the potential for broader clinical 
application.
Methods
PtLsCl probe. The PtLsCl probe was synthesised as described by us previously19. Other imaging dyes and 
stains were purchased from commercial suppliers (as indicated in the SI) and used as per the suppliers instruc-
tions, all other reagents were purchased from Sigma Aldrich (Poole, Dorset, U.K.).
Human melanoma cells. The human melanoma cell line C8161 was assessed for its ability to form and 
grow as an MCTS, using the liquid overlay method previously described16. Briefly, 100 µL of cells (1.2 × 105 
per mL) were added to each well of a 96-well plate previously coated with type V agarose (1.5% (w/v)) in the 
growth medium (EMEM). The cells were incubated at 37 °C, 5% CO2 and monitored overtime for spheroid 
production. Cell culture medium was refreshed every 2–3 days by replacing 100 µL with fresh medium. MCTS 
was imaged every day for 12 days using phase contrast light microscopy to detect spheroid formation (see SI, 
Fig. 1). Experiments were performed in triplicate. Analysis of MCTS using haemotoxylin & eosin, Ki-67 and 
Hypoxyprobe™ are detailed in the supplementary information, along with details of individual cell cultures and 
2D co-cultures. Spheroid growth and radius of the specific areas within spheroids was measured using ImageJ 
Figure 4. Z-stack lifetime distribution of PtLsCl in melanoma MCTS using one-photon PLIM.  
(A) representation of a MCTS area (red) imaged using one-photon PLIM across ~100 µm. (B) Lifetime 
distribution at different depth (z-stack, Scale bar 200 µm) of MCTS. (C) Lifetime values within three different 
regions (outer, middle, and inner) of MCTS were measured (15 lifetime values, from each data set taken at 
different depths). Average lifetime values are used to plot lifetime differences within regions of spheroid. 
Lifetime of central necrotic core becomes shorter towards the periphery of the spheroid. Results shown are 
mean ± SD (n = 5) (**) denotes statistically significant different when outer (proliferative area) was compared 
with inner necrotic area. (D) Lifetime distribution histogram of spheroid with PtLsCl.
www.nature.com/scientificreports/
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software (version 1.4 G). The mean values were calculated and sample statistical distribution was derived from a 
standard error, which was calculated using the formula: standard deviation/√ (count (range of number)).
Melanoma staining with PtLsCl. Staining with PtLsCL and imaging via one-photon PLIM is briefly 
described below for clarity, full details of staining spheroids with PtLsCL can be found in the SI. To prepare mela-
noma spheroids for PLIM microscopy, spheroids were removed after 6–8 days in culture and transferred to 35mm 
glass bottomed dishes (3–4 MCTS in each dish) and allowed to settle overnight at 37 °C, 5% (v/v) CO2 in full 
EMEM medium. Spheroids were then incubated with PtLsCl 100 µM for 12 hours (0.5% DMSO, in PBS). Before 
imaging, spheroids were washed with PBS (x3) and then immersed in PBS.
Phosphorescence Lifetime Image Mapping. Measurements were performed at the Central Laser 
Facility, Rutherford Appleton Laboratory, STFC, Oxford, UK. The set-up comprised a Nikon microscope con-
nected to a Becker and Hickl DCS-120 confocal scanning FLIM system and a Becker and Hickl 405 nm diode 
laser (BDL-405-SMC). Excitation and emission filters used were λex = 405 nm, λem = 500–550 nm, respectively. 
The diode laser was ‘on/off ’ controlled for PLIM imaging by the Becker and Hickl FLIM module. The lifetime 
imaging window was set to 32 µs, which included a laser on rise time of 2 μs. The field of view was made up of a 
128 × 128-pixel array.
Lifetime map analysis. Emission lifetime maps were constructed using Becker and Hickl SPCImage soft-
ware (version 3.89). Decay kinetics were best fit to a double exponential approximation on a pixel-by-pixel basis. 
Pixel binning and threshold function were kept constant for all measurements. Lifetime data collected on single 
cells were taken from three independent regions of interest for each cell line. PtLsCl phosphorescence lifetime was 
measured at three intercellular positions: (1) nucleus, (2) cytoplasm and (3) nucleoli with 14 independent sample 
points for each region, averaged and plotted against standard deviation (Figure SI3). PtLsCl lifetime was measured 
across the spheroids (100 µm across and 20 µm apart) and lifetime emission images were stacked together using 
ImageJ software (version 1.4 G) for a volume 3D image of the whole construct. Furthermore, PtLsCl phosphores-
cence lifetime values were measured at three regions of the spheroid: (1) outer; (2) middle and (3) central, which 
were averaged and plotted (n = 5 independent areas using xy coordinates for each spheroid area) against standard 
deviation. In order to check for any statistically significant differences, a paired t-test was performed. Results with 
p-values of ≤0.05 were considered statistically significant. All data was analysed using Graphpad Prism software, 
version 6.0 (Figs 3 and 4).
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